Table of Contents

• 1.   Market Introduction

  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders

• 2.   Research Methodology

  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study

• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Health Information Exchange Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Health Information Exchange Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Global Health Information Exchange Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Maternal Health Market, By Type of Pregnancy Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Intrauterine
      2. Ectopic
      3. Tubal
      4. Others

• 8.   Maternal Health Market, By Risks in Pregnancy Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. High
      2. Molar

• 9.   Maternal Health Market, By Complications Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Miscarriage
       1.1. Threatened
       1.2. Inevitable
       1.3. Complete
       1.4. Incomplete
      2. Premature Labor and Birth
      3. Preeclampsia
      4. Gestational Diabetes
      5. Placenta Previa
      6. Others

• 10.   Maternal Health Market, By Delivery Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Vaginal Delivery
      2. Cesarian Section
      3. Vacuum Extraction
      4. Forceps Delivery

• 11.   Maternal Health Market, By Care Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Pre Natal Care
      2. Post Natal Care

• 12.   Maternal Health Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Hormones
      2. Nutritives
      3. Analgesics
      4. Anti-infectives
      5. Other

• 13.   North America Health Information Exchange Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 14.   Latin America Health Information Exchange Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 15.   Europe Health Information Exchange Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 16.   Asia Pacific Health Information Exchange Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 17.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 18.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •       1. Agile Therapeutics (USA)
             1.1. Company Overview
             1.2. Product Portfolio
             1.3. SWOT Analysis
             1.4. Financial Overview
             1.5. Strategic Overview
          2. Fuji Latex Co (Japan)
             2.1. Company Overview
             2.2. Product Portfolio
             2.3. SWOT Analysis
             2.4. Financial Overview
             2.5. Strategic Overview
          3. Okamoto industries
             3.1. Company Overview
             3.2. Product Portfolio
             3.3. SWOT Analysis
             3.4. Financial Overview
             3.5. Strategic Overview
          4. Reckitt Benckiser Group Plc.(UK)
             4.1. Company Overview
             4.2. Product Portfolio
             4.3. SWOT Analysis
             4.4. Financial Overview
             4.5. Strategic Overview
          5. Sanofi (India)
             5.1. Company Overview
             5.2. Product Portfolio
             5.3. SWOT Analysis
             5.4. Financial Overview
             5.5. Strategic Overview          
          6. Johnson and Johnson(USA)
             6.1. Company Overview
             6.2. Product Portfolio
             6.3. SWOT Analysis
             6.4. Financial Overview
             6.5. Strategic Overview    
          7. McKinsey & Company
             7.1. Company Overview
             7.2. Product Portfolio
             7.3. SWOT Analysis
             7.4. Financial Overview
             7.5. Strategic Overview      
          8. MedTech Boston
             8.1. Company Overview
             8.2. Product Portfolio
             8.3. SWOT Analysis
             8.4. Financial Overview
             8.5. Strategic Overview      
          9. Merck Sharp & Dohme Corp.
             9.1. Company Overview
             9.2. Product Portfolio
             9.3. SWOT Analysis
             9.4. Financial Overview
             9.5. Strategic Overview      
        10. RAND Corporation
             10.1. Company Overview
             10.2. Product Portfolio
             10.3. SWOT Analysis
             10.4. Financial Overview
             10.5. Strategic Overview

• 20.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated
    by administrations
      5. The overall economic slowdown of the developing and developed nations

• 21.   FutureWise SME Key Takeaway Points for Client